Aleafia Health Q1 2023 Revenue Grows 41% YoY, What About Profit? Aleafia Health Inc. (OTCQX: ALEAF) (TSX:AH) revenue in Q1 2023 was $16.5 million, a 41% increase compared to $11.65 million in Q1 2022. Benzinga · Aug 11, 2022
Aleafia Health Hits Record $43.1M Net Revenue In 2022 15-Month Fiscal Year, Closes Debenture Amendment Transaction Aleafia Health Inc. (OTCQX: ALEAF) (TSX:AH) revenue for the 12 months period ending March 31, 2022 was $46.3 million compared to $30.08 million in the12 month period ending March 31, 2021. The fiscal year was changed to end on March 31. Benzinga · Jun 28, 2022
Aleafia Health Reaffirms Revenue Guidance, Implements $6.7 Million In Annualized Cost Savings Aleafia Health Inc. (TSX:AH) (OTCQX: ALEAF) reaffirmed its guidance with an announcement that it expects to achieve between $53 million and $63 million in net revenue in the current fiscal year. Benzinga · Apr 5, 2022
Aleafia Health Q4 Revenue Declines 42.1% QoQ To $8.8M, Reports Narrower Net Loss Aleafia Health Inc. (TSX:AH) (OTCQX: ALEAF) reported its financial results for the three and 12 months ended Dec, 31, reporting quarterly revenue of $8.8 million compared with $15.2 million in Q4 2020. Benzinga · Feb 15, 2022
Aleafia Health Announces Q4 Results & Conference Call Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF) will announce results from its three and 12-month periods ending December 31, 2021 on February 14, 2022. Benzinga · Feb 8, 2022
Aleafia Health Provides Further Update On Its Convertible Debt Aleafia Health Inc. (OTCQX: ALEAF) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022. Key Points: Benzinga · Feb 1, 2022